Janus kinase inhibitors - their current applications and future prospects
Janus kinase inhibitors are a group of drugs that provide an alternative to conventional therapy for numerous diseases. The most studied drug of this group is tofacitinib. They are used in cases of inadequate response to treatment, intolerance of first-line drugs or presence of severe side effects r...
Saved in:
Main Authors: | Natalia Wierzbowska (Author), Karolina Żurawska (Author), Maciej Arciszewski (Author), Arnold Kukowka (Author), Bolesław Banach (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of janus kinases in the treatment of autoimmune skin diseases
by: Arnold Kukowka, et al.
Published: (2021) -
Current pharmacotherapy of osteoporosis and its future
by: Arnold Kukowka, et al.
Published: (2021) -
Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
by: Sara Sadeghi, et al.
Published: (2022) -
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
by: Eric Toussirot
Published: (2022) -
Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)